Istraživači



Results 1-20 of 59
Issue DateTitleAuthor(s)TypeМp-cat.
2025A computational framework for the design and development of ERK2 and multi-target ERK2/HDAC inhibitorsCebzan, Alen; Ružić, Dušan  ; Đoković, Nemanja  ; Stanković, Branislav  ; Nikolić, Katarina  Article
21M21
2025P 01 Identification of Dual-Acting HDAC Inhibitors for Pancreatic Cancer Treatment through Drug Synergy Predictions and Molecular ModelingĐoković, Nemanja  ; Ilić, Aleksandra  ; Čebzan, Alen  ; Radović, Branko  ; Ružić, Dušan  ; Beljkaš, Milan  ; Đurić, Ana  ; Srdić-Rajić, Tatjana  ; Oljačić, Slavica  ; Nikolić, Katarina  Conference Paper
Mp. category will be shown later
2025Rational design of SIRT2 inhibitors: Integrating 3D-QSAR, molecular docking and machine learning techniquesIlić, Aleksandra  ; Đoković, Nemanja  ; Đikić, Teodora ; Nikolić, Katarina  Conference Paper
Mp. category will be shown later
2025Computer-Aided Drug Design of novel dual histone deacetylase inhibitorsIlić, Aleksandra  ; Beljkaš, Milan  ; Čebzan, Alen  ; Radović, Branko  ; Đoković, Nemanja  ; Nikolić, Katarina  ; Oljačić, Slavica  Conference Paper
Mp. category will be shown later
2024Integration of 3D-QSAR, molecular docking, and machine learning techniques for rational design of nicotinamide-based SIRT2 inhibitorsIlić, Aleksandra  ; Đoković, Nemanja  ; Đikić, Teodora ; Nikolić, Katarina  Article
21M21
2024Molecular dynamics examination of the cryptic subpocket of sirtuin 2Đoković, Nemanja  ; Marković, V; Nikolić, Katarina  Conference Paper
Mp. category will be shown later
2024Integrative Framework for Developing Innovative SIRT2 InhibitorsĐoković, Nemanja  ; Rahnasto‐Rilla, Minna; Đurić, Ana  ; Ružić, Dušan  ; Petković, Miloš  ; Srdić Rajić, Tatjana  ; Lahtela-Kakkonen, Maija; Nikolić, Katarina  Conference Paper
Mp. category will be shown later
2024Molecular modeling and design of new PI3K/HDAC dual inhibitorsBeljkaš, Milan  ; Kukić, E; Đoković, Nemanja  ; Oljačić, Slavica  Conference Paper
Mp. category will be shown later
2024Discovery of dual-acting HDAC inhibitors for the treatment of pancreatic cancer by combining drug synergy and molecular modelingĐoković, Nemanja  ; Ilić, Aleksandra  ; Čebzan, Alen  ; Radović, Branko  ; Ružić, Dušan  ; Beljkaš, Milan  ; Đurić, Ana  ; Srdić-Rajić, Tatjana  ; Oljačić, Slavica  ; Nikolić, Katarina  Conference Paper
Mp. category will be shown later
2024Design and ADMET prediction of novel dual inhibitors from the histone deacetylase familyIlić, Aleksandra  ; Čebzan, Alen  ; Radović, Branko  ; Đoković, Nemanja  ; Nikolić, Katarina  Conference Paper
Mp. category will be shown later
2023Discovery of novel HDAC inhibitors for therapy of triple-negative breast cancer – preclinical studyRužić, Dušan  ; Đoković, Nemanja  ; Santibanez, Juan  ; Pavić, Aleksandar  ; Ganesan, A.; Srdić- Rajić, Tatjana  ; Nikolić, Katarina  Conference Paper
Mp. category will be shown later
2023Simulacije molekulske dinamike, dizajn, sinteza i in vitro ispitivanje inhibitora epigenetskih proteina kao potencijalnih antineoplastikaĐoković, Nemanja  Doctoral theses
70M70
2023SIRT2i_Predictor: A Machine Learning-Based Tool to Facilitate the Discovery of Novel SIRT2 InhibitorsĐoković, Nemanja  ; Rahnasto-Rilla, Minna; Lougiakis, Nikolas; Lahtela-Kakkonen, Maija; Nikolić, Katarina  Article
21M21
2023Targeting Histone Deacetylases 6 in Dual-Target Therapy of CancerBeljkas, Milan  ; Ilić, Aleksandra  ; Cebzan, Alen  ; Radović, Branko  ; Đoković, Nemanja  ; Ružić, Dušan  ; Nikolić, Katarina  ; Oljačić, Slavica  Article
21aM21a
2023Reversible Control of RNA Splicing by Photoswitchable Small MoleculesZhang, Lei; Xie, Xiulan; Đoković, Nemanja  ; Nikolić, Katarina  ; Kosenkov, Dmitri; Abendroth, Frank; Vázquez, OlallaArticle
21a+M21a+
2023Correlating basal gene expression across chemical sensitivity data to screen for novel synergistic interactors of HDAC inhibitors in pancreatic carcinomaNemanja Djokovic  ; Ana Djuric  ; Dusan Ruzic  ; Tatjana Srdic-Rajic  ; Katarina Nikolic  Article
21M21
2023Towards the multitarget HDAC Inhibitors for the treatment of pancreatic carcinoma by joining the drug synergy predictions and the molecular modelingĐoković, Nemanja  ; Ilić, Aleksandra  ; Čebzan, Alen  ; Radović, Branko  ; Ružić, Dušan  ; Đurić, Ana  ; Srdić-Rajić, Tatjana  ; Nikolić, Katarina  Conference Paper
Mp. category will be shown later
2022Quinazoline-based analog of adenine as an antidote against MLL-rearranged leukemia cells: synthesis, inhibition assays and docking studiesBon, Corentin; Barbachowska, Magdalena; Đoković, Nemanja  ; Ružić, Dušan  ; Si, Yang; Soresinetti, Laura; Jallet, Corinne; Tafit, Ambre; Halby, Ludovic; Nikolić, Katarina  ;
Arimondo, Paola B;
Article
21M21
2022Novel protocol for enhanced sampling of binding pocket dynamics and its integration into the sirtuin 2 inhibitors virtual screening campaignĐoković, Nemanja  ; Ružić, Dušan  ; Rahnasto‐Rilla, Minna; Srdić-Rajić, Tatjana  ; Lahtela‐Kakkonen, Maija; Nikolić, Katarina  Conference Paper
Mp. category will be shown later
2022Targeting Histone Deacetylases: Opportunities for Cancer Treatment and ChemopreventionRužić, Dušan  ; Đoković, Nemanja  ; Srdić-Rajić, Tatjana  ; Echeverria, Cesar; Nikolić, Katarina  ; Santibanez, Juan  Article
21aM21a